HOXB9 and neoplasm: Orthotopic tumour models were developed from CD44+, CD44+ α2β1+, ALDH+ CD44+ α2β1+ and ALDH+ CD44+ CXCR4+ CD24+ cells with or without HOXB9 knockdown.